Home › Funds › ACT Capital Partners, L.P. › SGMT

ACT Capital Partners, L.P. position in SGMT

SAGIMET BIOSCIENCES INC · Health Care

ACT Capital Partners, L.P. reported holding 60,000 shares of SGMT (SAGIMET BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$593K, representing 0.40% of its reported portfolio and ranking #29 among its reported holdings. ACT Capital Partners, L.P. first reported this position in Q3 2026.

Latest position (Q3 2026)60.00K sh
Reported value held$592.80K
Portfolio Weight0.40%
First reportedQ3 2026
Last changeNew
Updated2026-11-07

Last updated: 2026-11-07 · Source: SEC EDGAR Form 13F-HR

How ACT Capital Partners, L.P.'s SGMT position evolved

ACT Capital Partners, L.P. first disclosed a stake in SGMT in Q3 2026 at 60,000 shares (US$593K).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 60.00K $592.80K New

About SGMT and 13F data

SGMT (SAGIMET BIOSCIENCES INC) is a Health Care company. 60 other funds we track also report a position in SGMT — the largest reported positions include SILVERARC CAPITAL MANAGEMENT, LLC (US$22.6M), BVF INC/IL (US$19.3M), Caligan Partners LP (US$19.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SGMT

All SGMT fund holders →

FAQ

How long has ACT Capital Partners, L.P. held SGMT?

ACT Capital Partners, L.P. has disclosed SGMT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is ACT Capital Partners, L.P.'s current position in SGMT?

As of Q3 2026, ACT Capital Partners, L.P. holds 60.00K shares of SGMT (SAGIMET BIOSCIENCES INC), valued at $592.80K, representing 0.40% of its reported portfolio and ranking #29.

Has ACT Capital Partners, L.P. been buying or selling SGMT?

In the latest 13F filing (Q3 2026), ACT Capital Partners, L.P. newly opened its position in SGMT.

Which other funds hold SGMT?

Other major institutional holders of SGMT include SILVERARC CAPITAL MANAGEMENT, LLC, BVF INC/IL, Caligan Partners LP, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.